Invenra has launched its Rapid Antibody Discovery Service, designed to simplify and de-risk the preclinical development of ...

It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.

A panelist discusses how loncastuximab tesirine, an antibody-drug conjugate targeting CD19, shows promise in combination with rituximab for R/R FL based on its complementary mechanism of action ...

By adapting artificial intelligence models known as large language models, researchers have made great progress in their ...

Using nasal swabs to identify a child’s asthma subtype may lead to more precise medication prescribing and development of ...

Tafasitamab increased progression free survival by about 9 months when compared to placebo, according to recent study data.

Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...

When children receive their second measles-mumps-rubella vaccine, around the time they start kindergarten, they gain protection against all three viruses for all or most of their lives.

LAT-010 is under clinical development by Latticon Antibody Therapeutics and currently in Phase II for Renal Cell Carcinoma.

Sacituzumab govitecan, currently indicated in triple-negative breast cancer (TNBC), is undergoing evaluation in NSCLC. In ...

LAT-010 is under clinical development by Latticon Antibody Therapeutics and currently in Phase II for Non-Small Cell Lung Cancer.

Roche acquires ADC rights from Innovent for lung cancer treatment in $1 billion deal Roche strengthens its global foothold in ...